IndiaMTF — home
Stock

Ajanta Pharma — MTF Book

AJANTPHARM · Ajanta Pharma Limited
Health Technology

Daily Margin Trading Facility book for Ajanta Pharma across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Ajanta Pharma’s MTF book?

Ajanta Pharma Limited (AJANTPHARM) has ₹22 crore funded under Margin Trading Facility across NSE and BSE as of 12 Aug 2026 — 0.01% of India’s MTF book, ranking #972. Over 1M (the last 30 trading days) the funded value has fallen 3.1%, with the number of shares under margin down 9.1%.

Funded value
₹22 Cr
as of 12 Aug 2026
Rank in book
#972
1,393 days tracked
Share of book
0.01%
of the whole NSE + BSE book
Peak funded
₹38 Cr
on 30 Jul 2026
Largest single-day addition
+₹12 Cr
on 25 Jul 2023
Largest single-day unwind
−₹10 Cr
on 01 Jan 2025
Free-float market cap
₹15,433 Cr
full market cap ₹42,249 Cr · 36.5% free float · Mid cap
MTF share of free float
0.14%
0.3× the median mid cap · 0.2× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.08%0.14%0.20%0.27%May 2024Aug 2026
View as table: share of free float on margin18 months
Month-end% of free float
12 Aug 2026†0.143%
31 Jul 20260.244%
30 Jun 20260.159%
29 May 20260.219%
24 Feb 2026†0.224%
31 Dec 20250.142%
28 Nov 20250.151%
31 Oct 20250.198%
30 Sep 20250.190%
29 Aug 20250.171%
31 Jul 20250.175%
30 Jun 20250.229%
30 May 20250.148%
30 Apr 20250.100%
28 Mar 20250.119%
28 Feb 20250.154%
31 Jan 20250.130%
03 May 2024†0.235%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How AJANTPHARM’s funded book divides across the two exchanges, as of 12 Aug 2026.
NSE
NSE ₹22 Cr · 96.8%BSE ₹1 Cr · 3.2%

MTF vs Price

Margin-funded outstanding for AJANTPHARM in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where AJANTPHARM has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

AJANTPHARM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
12 Aug 202622−₹10.01%972
11 Aug 202623−₹30.02%958
10 Aug 202626−₹10.02%896
07 Aug 202627−₹20.02%885
06 Aug 202629−₹20.02%854
05 Aug 202631−₹20.02%820
04 Aug 202633−₹10.02%795
03 Aug 202633−₹40.02%779
31 Jul 202637−₹10.03%737
30 Jul 202638+₹20.03%729
29 Jul 202636+₹00.03%749
28 Jul 202636+₹10.03%750
27 Jul 202634+₹30.02%760
24 Jul 202632+₹00.02%792
23 Jul 202631+₹00.02%798
22 Jul 202631+₹30.02%800
21 Jul 202628+₹50.02%835
20 Jul 202623−₹00.02%927
17 Jul 202623−₹00.02%918
16 Jul 202623+₹00.02%918
15 Jul 202623+₹10.02%929
14 Jul 202622+₹10.01%935
13 Jul 202621−₹20.01%949
10 Jul 202623−₹10.02%909
09 Jul 202624+₹10.02%888
08 Jul 202624−₹10.02%893
07 Jul 202625+₹00.02%886
06 Jul 202624−₹10.02%889
03 Jul 202625+₹20.02%879
02 Jul 202624—0.02%908
Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.